Abstract
A series of oxazolidinone and indole derivatives were synthesized and evaluated as IL-6 signaling blockers by measuring the effects of these compounds on IL-6-induced luciferase expression in human hepatocarcinoma HepG2 cells transfected with p-STAT3-Luc. Among different compounds screened, compound 4d was emerged as the most potent IL-6 signaling blockers with IC50 value of 5.9 μM which was much better than (+)-Madindoline A (IC50 = 21 μM), a known inhibitor of IL-6.
Original language | English |
---|---|
Pages (from-to) | 1282-1286 |
Number of pages | 5 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 26 |
Issue number | 4 |
DOIs | |
State | Published - 15 Feb 2016 |
Bibliographical note
Publisher Copyright:© 2016 Elsevier Ltd. All rights reserved.
Keywords
- IL-6 antagonists
- IL-6 signaling inhibitor
- Oxazolidinone
- Rheumatoid arthritis
- STAT3
- gp130